ATAI Life Sciences N.V. Profit Margin

ATAI Life Sciences N.V. (ATAI) currently reports a profit margin of -14938.37% as of June 2026. That compares with -5262.41% in the prior-year period — down 183.9% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore ATAI Life Sciences N.V.'s profit margin history and peer comparisons.

ATAI Life Sciences N.V.'s profit margin decreased from -5262.41% to -14938.37% — a 183.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ATAI Life Sciences N.V.'s profit margin of -14938.37% is lower than the Healthcare sector average of 13.89%. That is roughly 107623.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but ATAI Life Sciences N.V.'s current -14938.37% should be judged against Healthcare norms (sector average: 13.89%) and against ATAI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -14938.37%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for ATAI Life Sciences N.V., and consider following ATAI for alerts when major investors trade the stock.